Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (21-30 of 638) with videos related to

Pageof 64
Sort By:
Circulation Research|May 26, 2007
Peroxisome proliferator-activated receptors mediate pleiotropic actions of statinsRéjane Paumelle, Bart Staels
FEBS Letters|September 4, 2007
Rev-erb alpha gives a time cue to metabolismHélène Duez, Bart Staels
Current Atherosclerosis Reports|June 9, 2009
Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery diseaseCatherine Fiévet, Bart Staels
Nature Reviews. Endocrinology|August 21, 2021
Hepatic sexual dimorphism - implications for non-alcoholic fatty liver diseasePhilippe Lefebvre, Bart Staels
Diabetes & Vascular Disease Research|June 10, 2008
The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolismHélène Duez, Bart Staels
Current Obesity Reports|February 12, 2025
Circadian Disruption and the Risk of Developing ObesityHélène Duez, Bart Staels
Medecine Sciences : M/S|April 7, 2006
[The fibrate-activated PPARalpha/p16INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusion]Florence Gizard, Bart Staels
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2012
Naturally improving insulin resistance with amorfrutinsPhilippe Lefebvre, Bart Staels
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2015
SREBF2-embedded mir33 links the nuclear bile acid receptor FXR to cholesterol and lipoprotein metabolismPhilippe Lefebvre, Bart Staels
Drugs|June 30, 2007
Bile acid sequestrants and the treatment of type 2 diabetes mellitusBart Staels, Folkert Kuipers
Pageof 64

Showing results (21-30 of 638) with videos related to

Sort By:
Pageof 64
Circulation Research|May 26, 2007
Peroxisome proliferator-activated receptors mediate pleiotropic actions of statinsRéjane Paumelle, Bart Staels
FEBS Letters|September 4, 2007
Rev-erb alpha gives a time cue to metabolismHélène Duez, Bart Staels
Current Atherosclerosis Reports|June 9, 2009
Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery diseaseCatherine Fiévet, Bart Staels
Nature Reviews. Endocrinology|August 21, 2021
Hepatic sexual dimorphism - implications for non-alcoholic fatty liver diseasePhilippe Lefebvre, Bart Staels
Diabetes & Vascular Disease Research|June 10, 2008
The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolismHélène Duez, Bart Staels
Current Obesity Reports|February 12, 2025
Circadian Disruption and the Risk of Developing ObesityHélène Duez, Bart Staels
Medecine Sciences : M/S|April 7, 2006
[The fibrate-activated PPARalpha/p16INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusion]Florence Gizard, Bart Staels
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2012
Naturally improving insulin resistance with amorfrutinsPhilippe Lefebvre, Bart Staels
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2015
SREBF2-embedded mir33 links the nuclear bile acid receptor FXR to cholesterol and lipoprotein metabolismPhilippe Lefebvre, Bart Staels
Drugs|June 30, 2007
Bile acid sequestrants and the treatment of type 2 diabetes mellitusBart Staels, Folkert Kuipers
Pageof 64